| Nome |
# |
|
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities, file f01edd1c-1c0a-4c70-885c-3d35068ab9fc
|
180
|
|
Assessing eligibility for treatment in acute myeloid leukemia in 2023, file 925673c0-75f3-491a-ab96-35da1ee108f8
|
50
|
|
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913, file 400b6af1-21e6-428f-a0d5-786962008663
|
45
|
|
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia, file 2133b383-7b47-4e73-a0b8-90194e8be67a
|
43
|
|
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective?, file d6fe1439-874f-44b7-8887-89edf9b9f7f8
|
36
|
|
"Efficient Strategies for the Reuse of Surgical and FFP2/ KN95 Face Masks during the COVID-19 Pandemic: Home-Made and Ecological Choices for the Community", file f6516295-bb6e-4159-8030-afe72b25ae3b
|
25
|
|
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia, file 7e9181c9-fc02-4919-9e70-51ad9ac367d9
|
17
|
|
Prospective Evaluation of a Continuation Therapy with Midostaurin in Adult Patients with Core-Binding Factor Leukemia and Integrated Genetic Analysis: A Multi Center Phase II Study. Preliminary Results, file 4f3d573d-6a78-448c-8992-0e7da0a3ad7e
|
14
|
|
Multidimensional Results and Reflections on CAR-T: The Italian Evidence, file cb88908f-4be8-42ac-a738-7f67e1cea041
|
12
|
|
Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma, file 730b5a9c-ba99-4a6e-8f02-10da5e3e7454
|
11
|
|
Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review, file a5a05b03-18d1-4994-9676-df9bd8964a34
|
11
|
|
Occurrence of L1M Elements in Chromosomal Rearrangements Associated to Chronic Myeloid Leukemia (CML): Insights from Patient-Specific Breakpoints Characterization, file 12508453-cc9e-4277-9a5d-5a96b9540e19
|
10
|
|
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol, file 613339b5-941e-4152-894f-c6dc1695872c
|
10
|
|
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi, file ea09c0e1-ca76-4b9e-834a-6874da71604d
|
10
|
|
Use of Sorafenib in FLT3-Mutant Myeloid Sarcoma: A Case Report, file 2fdad660-5389-4027-8652-4f0d1e008ef5
|
9
|
|
Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment, file 59a237ce-b49a-4be8-906b-1db64bafebc8
|
9
|
|
Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study, file 62297622-e7ae-4a59-bbf1-7ce9a5e93e16
|
7
|
|
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy, file 98944075-ba4f-4952-9597-513f4e42c50a
|
7
|
|
Myeloma’s multiple morphologies, file a888cf68-4289-4ef1-a652-9204e5a6f061
|
7
|
|
Genes and Pathways Dysregulated by Nilotinib Treatment in Bone Marrow CD34+/Lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukaemia, file b9a83495-e9a0-4c26-bbf3-ba0e71fed126
|
7
|
|
Prognostic markers in AML: focus on CBFL, file 14a80e7a-9450-4181-b2df-080bd2e02cf4
|
6
|
|
FZD6 triggers Wnt–signalling driven by WNT10BIVS1 expression and highlights new targets in T-cell acute lymphoblastic leukemia, file 76c98b49-157c-4159-945d-c05e27b67c4b
|
6
|
|
Should Patients with Waldenström Macroglobulinemia Receive a BTK Inhibitor as Frontline Therapy?, file d7e90451-b870-4a4b-ba77-75b8360d3c94
|
6
|
|
Safety and efficacy of NEPA and dexamethasone in Hodgkin's lymphoma patients: a single-center real-life experience, file e23cecc6-9e69-4ab3-b5a7-48d9824ee495
|
6
|
|
Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia, file 1b172ba5-ffa3-4eca-871e-78930b52e559
|
5
|
|
c-kit activating mutations and mast cell proliferation in human leukemia [4], file 312a68ad-c822-40fb-81e7-c19eb4e63898
|
5
|
|
Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial, file 95063f13-7744-457c-bbfb-87023e4cbfee
|
5
|
|
Identification of a candidate gene set signature for the risk of progression in igm mgus to smoldering/symptomatic waldenström macroglobulinemia (Wm) by a comparative transcriptome analysis of b cells and plasma cells, file a814263f-a87c-4a25-b124-86446f36d145
|
5
|
|
Gene Expression Profiling of Waldenström's Macroglobulinemia vs. IgM Monoclonal Gammopathy of Undetermined Significance, file ba084366-ae96-45fd-8c4e-b3d37e224b03
|
5
|
|
Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia, file d374503d-94f9-4bac-bc44-032d754e6761
|
5
|
|
A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry, file 21aba305-0168-4b6a-b596-704377b83f9f
|
4
|
|
Cordycepin (3′dA) Induces Cell Death of AC133+ Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC, file 2b8dfc97-92ba-4283-b53a-5f6f0dbef8d3
|
4
|
|
A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting, file 51a27b21-6116-40a9-a149-b5ca5b3de5bd
|
4
|
|
Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine, file 74d877cc-f855-42d0-a924-338210463555
|
4
|
|
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients, file 8dfce193-f65f-4687-9ba4-19c4a82bb77d
|
4
|
|
SOHO State of the Art Updates and Next Questions: What is Fitness in the Era of Targeted Agents?, file 9181c176-ed46-49ec-98d2-52977bab86c6
|
4
|
|
Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia, file b7d07a69-cac5-43ba-995a-f7c42bd697ec
|
4
|
|
Plasma cell-directed therapy and anti-HLA antibody production: A successful combination?, file c4e88b1c-80c6-410e-a393-bdf941cb4f40
|
4
|
|
Gastrointestinal Kaposi's Sarcoma in a Woman with Selective IgA Deficiency and prior Immunosuppressive therapy for Idiopathic Thrombocitopenioc Purpura, file d88d0dae-cf1d-49d5-8ee2-951409c9a2ee
|
4
|
|
Monoclonal Antibodies in Chronic Lymphocytic Leukemia, file e4bdd5b8-7bb7-4b37-b514-31b8c213a851
|
4
|
|
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers, file e743cc06-2731-4a53-b9ae-63abad00a477
|
4
|
|
Management of patients with acute myeloid leukemia undergoing therapy with midostaurin: a focus on antifungal prophylaxis, file fee64592-49ce-4204-a35a-ad4e50e162f8
|
4
|
|
Nilotinib induced bone marrow CD34+/lin–Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia, file 03fe3e14-a47d-4adc-a9c0-af6b1540f7b5
|
3
|
|
A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis, file 081ca2dd-26b1-4d6a-9fa7-ba8d51902458
|
3
|
|
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL), file 11a0555a-ef61-4903-8fe0-8568ecada3e4
|
3
|
|
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV, file 12fdcfce-2c4d-45b2-ad91-cd500d2845c0
|
3
|
|
STI 571 inhibition effect on KITAsn822Lys-mediated signal transduction cascade, file 4d6b2ee5-039d-4c9f-b889-adf36df7b2d5
|
3
|
|
Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta, file 647a8460-9aa5-48fc-b41f-424bff2452d6
|
3
|
|
C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index, file 85586419-0e02-4222-8303-295dda562a65
|
3
|
|
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia, file 8f3a5ef7-eba1-4601-8870-d087df43bbfc
|
3
|
|
Down-regulation of micrornas 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits, file 8f80b356-32b0-4773-a4f7-139a56ddd86c
|
3
|
|
Prognostic impact of immunohistochemical p53 expression in bone marrow biopsy in higher risk MDS: A pilot study, file 92302487-bb7b-4642-a5cd-f5518911af90
|
3
|
|
Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia, file c04e2dcc-fc85-42fb-94f6-730e6a103c0e
|
3
|
|
Health-related quality of life in Waldenstrom Macroglobulinemia and IgM-related disorders: A single institution experience, file c9b197b6-79fa-4f47-baf4-ecbdc499e999
|
3
|
|
Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis, file cf3cb018-c165-4142-aeb0-b41894b97724
|
3
|
|
Outcome of patients with chronic myeloid leukemia and a low-risk score: Allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party, file e8a608c9-a4fa-4db9-83a0-35b6cf8803fc
|
3
|
|
A novel start-loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms, file ecb64c0d-9e23-47e4-87c4-afc072b899cb
|
3
|
|
Abnormalities of cytoskeletal proteins of the red blood cells in myelodysplastic syndromes, file ffdea010-9312-41cf-a068-d0f93d92f019
|
3
|
|
Safety of recreational scuba diving in type 1 diabetic patients: the Deep Monitoring programme, file 01a1f314-a5bd-4434-8c68-2f069180e7a8
|
2
|
|
Flow cytometry and cytomorphology evaluation of hematologic malignancy in cerebrospinal fluids: Comparison with retrospective clinical outcome, file 05ad3436-a403-4e1f-98c7-9cff4d0d34f4
|
2
|
|
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study, file 0ac64134-9994-4c62-843d-45f365464276
|
2
|
|
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes, file 1b056721-c8f1-45d4-ae31-e798101251c8
|
2
|
|
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia, file 1c842c57-3956-4df7-a4e7-cf678286b8e0
|
2
|
|
Duvelisib for the treatment of chronic lymphocytic leukemia, file 1ce90213-bebf-4ca3-a440-4ca14d1e1ea8
|
2
|
|
Untunnelled central venous catheters in the treatment of acute leukemia, file 2172e860-167f-4b41-a913-8d1751e76c24
|
2
|
|
Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy, file 2541b512-6f5e-4975-96c2-ac9e4234820d
|
2
|
|
A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis, file 2b5dd2b0-5a3f-480a-a7f3-a54c29390881
|
2
|
|
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study, file 316f4aaf-a11b-4b02-b6e7-03e24eeadc51
|
2
|
|
Answer from authors about the article "Safety of recreational scuba diving in type 1 diabetic patients: The Deep Monitoring programme", file 3bafc1ea-3e6f-42e0-a94c-9696256d52c2
|
2
|
|
Bing Neel Syndrome in a Previously Untreated Patient with Waldenström's Macroglobulinemia: Contribution of MYD88 L265P Mutation on Cerebrospinal Fluid, file 3c5a8710-c35c-4262-ac36-d94e2a51129c
|
2
|
|
Saccharomyces cerevisiae fungemia with granulomas in the bone marrow in a patient undergoing BMT, file 425ecb24-25d3-4b2c-a607-6000edbc5e26
|
2
|
|
Response loss and development of neutralizing antibodies during long-term treatment with romiplostim in patients with immune thrombocytopenia: a case series, file 45558f50-c106-4b1e-a536-bb02a0e2d0df
|
2
|
|
Prognostic value of circulating CD34+ cells in myelodysplastic syndromes, file 45f1dd51-58d9-4cda-b5f2-2a854e99e4b9
|
2
|
|
Waldenstrom's macroglobulinemia: An update, file 4a668cb6-83a1-4b19-9779-a3862e6afa4b
|
2
|
|
A PROPOSAL OF MULTI-DIMENSIONAL EVALUATION OF ELDERLY PATIENTS AFFECTED BY MDS: THE "NO-CHAIN" ALGORITHM, file 4cc68871-ebc1-4f65-bc95-4035a895007b
|
2
|
|
Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia?, file 4f2c3415-5dda-413c-95e8-1f11a075a216
|
2
|
|
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19, file 508814b7-c9ce-4a97-9318-e4e72012aff9
|
2
|
|
Clinical relevance of anti-platelet antibodies and the hepatic clearance of platelets in patients with immune thrombocytopenia (ITP), file 5186793f-72ed-46de-b00a-3098ee72f3f3
|
2
|
|
Ibrutinib and its use in the treatment o chronic lymphocytic leukemia, file 51c870fe-a5d0-49e6-adfd-693981bb643d
|
2
|
|
Panobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant, file 51ea960b-6dd6-4287-87ab-66fb88e1e377
|
2
|
|
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma, file 52c6f73e-035b-457e-90c1-059abe1ff169
|
2
|
|
Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis, file 59bbdb16-15e5-4e1b-86ba-8010bd1f4066
|
2
|
|
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H, file 5c6024e6-1296-4b56-a7ca-8391b76fde21
|
2
|
|
The ERK1/2 Regulator WNK2 Shows Novel Alternative Splicing Aberrations That Support Tumor Growth in MYD88 Mutated Waldenstrom's Macroglobulinemia, file 5cd4a161-5868-42f9-87c9-d66aa805d833
|
2
|
|
Primary Results of Stimulus-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition with Sabatolimab Added to Hypomethylating Agents (HMAs) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS), file 5d0f5f3b-5bed-4959-8dcd-2ffbf1a1bff2
|
2
|
|
Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation, file 61b44fbb-f7fd-4f20-ae7a-b16fd7c94b78
|
2
|
|
Detection by polymerase chain reaction of BCR/ ABL transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantation, file 6364e021-35f6-4341-b00a-358161cb5aca
|
2
|
|
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation, file 653eb7cb-21a1-4960-83d5-c43b2d076abb
|
2
|
|
Limited feasibility of double transplant in multiple myeloma: Results of a multicenter study on 153 patients aged <65 years, file 66f6e1ef-ceb0-4abf-9c38-e669b40a3fcd
|
2
|
|
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996, file 6a9ce8aa-6cc7-4d19-afcf-c850ff31def5
|
2
|
|
Paving the way for new agents; is standard chemotherapy part of the treatment paradigm for chronic lymphocytic leukemia in the future?, file 6dfdcb09-7561-4a73-b05e-07b3cc91268a
|
2
|
|
Prior invasive pulmonary and cerebellar mucormycosis is not a primary contraindication to perform an autologous stem cell transplatation in leukemia., file 7157c504-4d0d-41b4-9f76-5809e4abb183
|
2
|
|
PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation, file 72cebc30-dc62-44e2-a846-c6e1324c86ee
|
2
|
|
Regeneration-associated WNT Signaling Is Activated in Long-term Reconstituting AC133(bright) Acute Myeloid Leukemia Cells, file 7bf9dd09-fd4a-49f3-b312-18f8fae8cfe5
|
2
|
|
Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy), file 7dd18f08-9fdc-4c7c-bca4-40e4118e9f43
|
2
|
|
C-kit mutations in core binding factor leukemias, file 845153b9-ed2b-4230-a3cb-65db0a942bc8
|
2
|
|
Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations. A report of three cases, file 84b17d16-4113-47ec-a601-b5416acb25d2
|
2
|
|
Is HBV prophylaxis required during CLL treatment with ibrutinib?, file 856e1e2d-3f18-4018-a825-c28cd54d049f
|
2
|
|
The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda", file 86abde05-db50-46e6-9dd3-02d78c586cf1
|
2
|
|
DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma, file 87bb5cde-d5b7-4251-8d66-e864ade77604
|
2
|
| Totale |
754 |
